34 related articles for article (PubMed ID: 38513335)
1. Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.
Neuner EA; Gallagher JC
Virulence; 2017 May; 8(4):440-452. PubMed ID: 27589330
[TBL] [Abstract][Full Text] [Related]
2. Combination Therapy for OXA-48 Carbapenemase-Producing
Chen Y; Fang C; Luo J; Pan X; Gao Z; Tang S; Li M
Infect Drug Resist; 2024; 17():1987-1997. PubMed ID: 38800585
[TBL] [Abstract][Full Text] [Related]
3. Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.
van Duin D; Lok JJ; Earley M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Doi Y; Kaye KS; Fowler VG; Paterson DL; Bonomo RA; Evans S;
Clin Infect Dis; 2018 Jan; 66(2):163-171. PubMed ID: 29020404
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant
Amladi AU; Abirami B; Devi SM; Sudarsanam TD; Kandasamy S; Kekre N; Veeraraghavan B; Sahni RD
Indian J Med Res; 2019 Feb; 149(2):185-191. PubMed ID: 31219082
[TBL] [Abstract][Full Text] [Related]
5. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
[TBL] [Abstract][Full Text] [Related]
6. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
[TBL] [Abstract][Full Text] [Related]
7. High rate of colistin and fosfomycin resistance among carbapenemase-producing Enterobacteriaceae in Turkey.
Süzük Yıldız S; Kaşkatepe B; Şimşek H; Sarıgüzel FM
Acta Microbiol Immunol Hung; 2019 Mar; 66(1):103-112. PubMed ID: 30403361
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis.
Katip W; Rayanakorn A; Oberdorfer P; Taruangsri P; Nampuan T; Okonogi S
J Infect Public Health; 2024 May; 17(5):727-734. PubMed ID: 38513335
[TBL] [Abstract][Full Text] [Related]
9. Management of carbapenem-resistant Enterobacteriaceae infections.
Durante-Mangoni E; Andini R; Zampino R
Clin Microbiol Infect; 2019 Aug; 25(8):943-950. PubMed ID: 31004767
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.
Trecarichi EM; Tumbarello M
Virulence; 2017 May; 8(4):470-484. PubMed ID: 28276996
[TBL] [Abstract][Full Text] [Related]
11. Options for treating carbapenem-resistant Enterobacteriaceae.
Rafailidis PI; Falagas ME
Curr Opin Infect Dis; 2014 Dec; 27(6):479-83. PubMed ID: 25259809
[TBL] [Abstract][Full Text] [Related]
12. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.
Zusman O; Altunin S; Koppel F; Dishon Benattar Y; Gedik H; Paul M
J Antimicrob Chemother; 2017 Jan; 72(1):29-39. PubMed ID: 27624572
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
